DataVXAdvanced Materials InterfacesPaper
journal article·2023-04Open access

g‐C3N4 Monolayer/2D Mica Nanohybrids with Highly Effective UV–HEV‐Screening Function

Huiyan Piao, Goeun Choi, N. Sanoj Rejinold, Ajayan Vinu, Jin‐Ho Choy

Advanced Materials Interfaces· Volume 10· Issue 12
Publisher pageOpen full text
Source abstract

Abstract

Abstract Excessive exposure to ultraviolet (UV) and high‐energy visible (HEV) light can cause sunburns, wrinkles, and even skin cancer. Therefore, the development of effective UV–HEV‐shielding agents is of great importance to human health. In this study, semiconducting graphitic carbon nitride (g‐C3N4) is incorporated into the interlayer space of mica through the intercalation of cyanamide and subsequent pyrolysis reactions to form a semiconductor–insulator nanohybrid, namely g‐C3N4–mica, with a 1:1 heterostructure. The g‐C3N4–mica nanohybrid exhibits excellent UV–HEV absorption properties below 450 nm, and its photocatalytic activity is quenched owing to the effective screening of photocatalytic active sites by the insulating mica. It is strongly believed that the proposed g‐C3N4–mica nanohybrid can be applied as a UV–HEV blocking agent owing to its excellent UV–HEV (200–450 nm)‐screening property without any photocatalytic effect or phototoxicity.
Source: crossref · Quality: baseline

Research context

NanomaterialsElectronic materialsCatalysis & surfaces

OpenAlex topics: Advanced Photocatalysis Techniques · Ga2O3 and related materials · ZnO doping and properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry National Demonstration Centre for Experimental Chemistry Education Yanbian University Yanji Jilin 133002 China

Intelligent Nanohybrid Materials Laboratory (INML) Institute of Tissue Regeneration Engineering (ITREN) Dankook University Cheonan 31116 Republic of Korea

College of Science and Technology Dankook University Cheonanm 31116 Republic of Korea

Department of Nanobiomedical Science and BK21 PLUS NBM Global Research Center for Regenerative Medicine Dankook University Cheonan 31116 Republic of Korea

Global Innovative Centre for Advanced Nanomaterials (GICAN) College of Engineering Science and Environment (CESE) School of Engineering The University of Newcastle Callaghan 2308 Australia

Department of Pre‐medical Course College of Medicine Dankook University Cheonan 31116 Republic of Korea

International Research Frontier Initiative (IRFI) Institute of Innovative Research Tokyo Institute of Technology Yokohama 226–8503 Japan

Funding

Ministry of Education

References (44)

Show source-provided references
1. 10.1038/s41467-018-06273-310.1038/s41467-018-06273-3 ↗
2. 10.1126/science.278.5339.82710.1126/science.278.5339.827 ↗
3. 10.1038/ncomms189310.1038/ncomms1893 ↗
4. 10.1016/S0300-483X(03)00150-110.1016/S0300-483X(03)00150-1 ↗
5. 10.1093/mnrasl/slx04710.1093/mnrasl/slx047 ↗
6. 10.1016/j.arr.2009.05.00410.1016/j.arr.2009.05.004 ↗
7. 10.1039/c2pp25152c10.1039/c2pp25152c ↗
8. 10.1002/polb.2308710.1002/polb.23087 ↗
9. 10.1021/am506696k10.1021/am506696k ↗
10. 10.1016/j.polymdegradstab.2005.06.00610.1016/j.polymdegradstab.2005.06.006 ↗
11. 10.1039/c4tc00437j10.1039/c4tc00437j ↗
12. 10.1039/C6TA00900J10.1039/C6TA00900J ↗
13. 10.1021/acsami.5b0423110.1021/acsami.5b04231 ↗
14. 10.1021/ja809307s10.1021/ja809307s ↗
15. 10.1021/ja512179x10.1021/ja512179x ↗
16. 10.1039/C6CS00532B10.1039/C6CS00532B ↗
17. 10.1002/adma.20190463510.1002/adma.201904635 ↗
18. 10.1002/marc.20200067610.1002/marc.202000676 ↗
19. 10.1007/s12274-019-2589-z10.1007/s12274-019-2589-z ↗
20. 10.1016/j.cattod.2014.08.03610.1016/j.cattod.2014.08.036 ↗
21. 10.1039/c2ee03479d10.1039/c2ee03479d ↗
22. 10.1007/s40820-022-00794-910.1007/s40820-022-00794-9 ↗
23. 10.1039/c2jm00097k10.1039/c2jm00097k ↗
24. 10.1021/la900923z10.1021/la900923z ↗
25. 10.1002/adma.20040164310.1002/adma.200401643 ↗
26. 10.1002/adfm.20070078310.1002/adfm.200700783 ↗
27. 10.1002/adma.20150003310.1002/adma.201500033 ↗
28. 10.1039/C4RA12880J10.1039/C4RA12880J ↗
29. 10.1038/s41598-019-47139-y10.1038/s41598-019-47139-y ↗
30. 10.1038/ncomms528410.1038/ncomms5284 ↗
31. 10.1002/anie.20110118210.1002/anie.201101182 ↗
32. 10.1002/ange.20120901710.1002/ange.201209017 ↗
33. 10.1039/C8EE01316K10.1039/C8EE01316K ↗
34. 10.1039/C5TA02257F10.1039/C5TA02257F ↗
35. Zhao L. · Chem · 2015 · 51
36. 10.1021/ie901092n10.1021/ie901092n ↗
37. 10.1021/acsami.2c0572610.1021/acsami.2c05726 ↗
38. 10.1039/D0SM02007A10.1039/D0SM02007A ↗
39. 10.5402/2012/35213510.5402/2012/352135 ↗
40. Food and Drug Administration Fed. Register 2011 76 35620.
41. 10.1088/0022-3727/38/15/00610.1088/0022-3727/38/15/006 ↗
42. 10.1117/1.307880210.1117/1.3078802 ↗
43. Iavicoli I. · Riv. Eur. Sci. Med. Farmacol. · 2011 · 15 · 481
44. 10.1186/1743-8977-6-1710.1186/1743-8977-6-17 ↗